#+TITLE: Summary of "Sweat and sour: an update on classic galactosemia"
#+AUTHOR: Matthew Henderson, PhD, FCACB
#+DATE: \today

:PROPERTIES:
#+DRAWERS: PROPERTIES
#+LaTeX_CLASS: beamer
#+LaTeX_CLASS_OPTIONS: [presentation, smaller]
# #+BEAMER_THEME: Ilmenau [height=20pt]
# #+BEAMER_THEME: Szeged  [height=20pt]
#+BEAMER_THEME: Boadilla [height=20pt]
#+BEAMER_COLOR_THEME: [RGB={170,160,80}]{structure}
#+BEAMER_FRAME_LEVEL: 1
#+COLUMNS: %40ITEM %10BEAMER_env(Env) %9BEAMER_envargs(Env Args) %4BEAMER_col(Col) %10BEAMER_extra(Extra)
#+OPTIONS: H:1 toc:nil ^:{}
#+STARTUP: beamer
#+STARTUP: overview
#+STARTUP: hidestars
#+STARTUP: indent
# #+BEAMER_HEADER: \subtitle{Screen Positive Rate Investigation}
#+BEAMER_HEADER: \institute[NSO]{Newborn Screening Ontario}
#+BEAMER_HEADER: \titlegraphic{\includegraphics[height=1cm,keepaspectratio]{../logos/NSO_logo.pdf}\includegraphics[height=1cm,keepaspectratio]{../logos/cheo-logo.png} \includegraphics[height=1cm,keepaspectratio]{../logos/UOlogoBW.eps}}
#+latex_header: \hypersetup{colorlinks,linkcolor=gray,urlcolor=blue}
#+LaTeX_header: \usepackage{textpos}
#+LaTeX_header: \usepackage{textgreek}
#+LaTeX_header: \usepackage[version=4]{mhchem}
#+LaTeX_header: \usepackage{chemfig}
#+LaTeX_header: \usepackage{siunitx}
#+LaTeX_header: \usepackage{gensymb}
#+LaTex_HEADER: \usepackage[usenames,dvipsnames]{xcolor}
#+LaTeX_HEADER: \usepackage[T1]{fontenc}
#+LaTeX_HEADER: \usepackage{lmodern}
#+LaTeX_HEADER: \usepackage{verbatim}
#+LaTeX_HEADER: \usepackage{tikz}
#+LaTeX_HEADER: \usetikzlibrary{shapes.geometric,arrows,decorations.pathmorphing,backgrounds,positioning,fit,petri}
:END:

#+BEGIN_EXPORT LaTeX

\logo{\includegraphics[width=1cm,height=1cm,keepaspectratio]{../logos/NSO_logo_small.pdf}}

\vspace{220pt}
\beamertemplatenavigationsymbolsempty
\setbeamertemplate{caption}[numbered]
\setbeamerfont{caption}{size=\tiny}
% \addtobeamertemplate{frametitle}{}{%
% \begin{textblock*}{100mm}(.85\textwidth,-1cm)
% \includegraphics[height=1cm,width=2cm]{cat}
% \end{textblock*}}


\tikzstyle{chemical} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=black, fill=none]
\tikzstyle{hardware} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=black, fill=gray!30]
\tikzstyle{ms} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=orange, fill=none]
\tikzstyle{msw} = [rectangle, rounded corners, text width=7em, minimum height=1em,text centered, draw=orange, fill=none]
\tikzstyle{label} = [rectangle,text width=8em, minimum height=1em, text centered, draw=none, fill=none]
\tikzstyle{hl} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=black, fill=red!30]
\tikzstyle{box} = [rectangle, rounded corners, text width=5em, minimum height=5em,text centered, draw=black, fill=none]
\tikzstyle{arrow} = [thick,->,>=stealth]
\tikzstyle{hl-arrow} = [ultra thick,->,>=stealth,draw=red]

#+END_EXPORT


* Classical galactosemia
- Caused by deficient activity of galactose-1-phosphate uridylyltransferase
- prevalence is 1:16,000-60,000 live births
- autosomal recessive
  - 336 mutations is the GALT gene described 

- presents in the neonatal period
  - potentially lethal

- Therapy is life long dietary galactose restriction
  - does not prevent long-term complications

* Galactose
- Primary source is dietary lactose
- Functions
  - energy source in pre-weaning infants
  - glycosylation
  - glycolipid synthesis


#+CAPTION[lactose]:Lactose is a disaccharide derived from the condensation of galactose and glucose, which form a \beta 1 \to 4 glycosidic linkage.
#+NAME: fig:lactose
#+ATTR_LaTeX: :width 0.4\textwidth
[[file:./figures/Beta-D-Lactose.png]]


* Galactose metabolism 

#+CAPTION[met]:Galactose metabolism
#+NAME: fig:met
#+ATTR_LaTeX: :width 0.8\textwidth
[[file:./figures/Fig1.png]]


* GALT Protein
- ubiquitous enzyme

#+CAPTION[structure]:Crystal structure
#+NAME: fig:struct
#+ATTR_LaTeX: :width 0.8\textwidth
[[file:./figures/Fig2.png]]


* GALT catalytic mechanism

#+CAPTION[mechanism]:Catalytic mechanism
#+NAME: fig:mech
#+ATTR_LaTeX: :width 0.8\textwidth
[[file:./figures/Fig3.png]]


* GALT gene
- 9p13, 11 exons, ~4 kb 
- housekeeping
** c.563A>G, p.Q188R
- ~64% of galactosemic alleles in caucasian pop
- Irish Travellers 1:430
- Non-functional variant: Destabilise UMP-GALT
  - no residual RBC GALT activity

** c.855G>T, p.K285N
- slavic origin?
- no residual RBC GALT activity

* Duarte and Los Angles variants
- Duarte (p.N314D) - 50% RBC GALT enzyme activity
- LA (p.N314D) - elevated RBC GALT enzyme activity
- Same electrophoretic pattern
- D is in linkage disequilibrium w a 4bp promoter deletion 
- p.D314 is the ancestral allele 
- p.N314 arose early in human evolution


* Biochemical Features
- \uparrow  Galatactose
- \uparrow Gal-1-p - pathogenic
- \uparrow  galactitol - cataracts
- \uparrow galactonate
- \downarrow UPD-Gal - disordered glycosylation, glycolipids
- \downarrow UPD-Glc

* Acute Presentation 
- asymptomatic at birth
- with feeding:
  - poor weight gain, vomiting, diarrhea
  - hepatocellular damage, lethargy, and hypotonia
- May progress to Gram negative sepsis, cataracts

* NBS
- not universal
  - must be identified early
  - \lt 5 days is ideal

* Spotcheck Method

#+BEGIN_EXPORT LaTeX
\ce{Gal-1-P + UDP-Glu ->[GALT] Glu-1-P + UDP-Gal}

\ce{Glu-1-P ->[PGluM] Glu-6-P}

\ce{Glu-6-P + NADP ->[G6PD] 6-PG + NADPH}

\ce{NADPH + MTT ->[methoxy PMS] Coloured Formazan + NADP}

#+END_EXPORT

* Diagnosis
- reducing substances in urine - not specific or sensitive
- Gal-1-P, galactose, galactitol in blood or urine
- RBC Gal-1-P - not specific
- RBC GALT activity
  - Classic galactosemia - undetectable or 1% of controls

* Therapy and Outcome

** Therapy
- life long dietary restriction of galactose.

** Outcome
- Endogenous galactose synthesis may be responsible for:
  - Cognitive impairment
  - Ovarian insufficiency
- Dairy restrictions
  - Bone health 
